Grow your business safely with FORAPHARMA

All the information you need about FORAPHARMA to develop and secure your business in France

F HOME > CORPORATES > FORAPHARMA > BALANCE SHEET ( 2021-01-26)

THE LIST OF BALANCE SHEET : FORAPHARMA

CORPORATEBOBACCESTABLISHMENTSMANAGERSFINANCE
Deposit Confidentiality closing date document
2022-11-03 Public 2022-03-31 Complete
2021-10-27 Public 2021-03-31 Complete
2021-01-26 Public 2020-03-31 Complete
2019-09-05 Public 2019-03-31 Complete
2018-08-06 Public 2018-03-31 Complete
2017-06-14 Public 2016-12-31 Complete
NameFORAPHARMA
Siren790863443
Closing2020-03-31
Registry code 7608
Registration number 524
Management number2013B00319
Activity code 7022Z
Closing date n-12019-03-31
Duration Fiscal year 12
Duration Fiscal year n-112
Filing date2021-01-26
Modification00 Annual accounts entered without anomaly
Balance sheet typeC : Complete
Currency codeEUR
ConfidentialityPublic
Address76120 Le Grand-Quevilly
1 - Assets (balance sheet)Gross amount year NAmortization year NNet year NNet year N-1
BJ TOTAL (I) 45 757.00 45 757.00 45 757.00
BZ Other receivables 56 013.00 56 013.00 56 013.00
CJ TOTAL (II) 56 013.00 56 013.00 56 013.00
CO Grand total (0 to V) 101 770.00 101 770.00 101 770.00
CU Other investments 45 757.00 45 757.00 45 757.00
2 - Liabilities (balance sheet)Amount year NAmount year N-1
DA Share or individual capital 10 000.00 10 000.00 10 000.00
DD Legal reserve (1) 1 000.00 1 000.00 1 000.00
DH Retained earnings 31 986.00 22 889.00 31 986.00
DI RESULTS FOR THE YEAR (Profit or Loss) 10 201.00 9 096.00 10 201.00
DL TOTAL (I) 53 187.00 42 986.00 53 187.00
DU Loans and Debts from Credit Institutions (3) 848.00 3.00 848.00
DX Trade payables and related accounts 2 000.00 2 412.00 2 000.00
DY Tax and social security liabilities 39.00
EA Other liabilities 45 734.00 45 734.00
EC TOTAL (IV) 48 582.00 2 454.00 48 582.00
EE Grand total (I to V) 101 770.00 45 440.00 101 770.00
EG Accrued income and payables due within one year 48 582.00 2 454.00 48 582.00
EH Including current bank overdrafts and credit balances from banks and postal accounts 848.00 3.00 848.00
3 - Income statementAmount France year NAmount Export year NTotal year NTotal year N-1
FQ Other income 14 381.00
FR Total operating income (I) 14 381.00
FW Other purchases and external expenses 2 210.00
FX Taxes, duties, and similar payments -39.00
GF Total Operating Expenses (II) 2 171.00
GG - OPERATING RESULT (I - II) 12 210.00
GJ Financial income from other securities and fixed asset receivables 27.00
GL Other interest and similar income 81.00
GP Total financial income (V) 108.00
GV - FINANCIAL INCOME (V - VI) 108.00
GW - CURRENT INCOME BEFORE TAX (I - II + III - IV + V - VI) 12 318.00
4 - Income statement (continued)Amount year NAmount year N-1
HK Income tax 2 117.00 1 826.00 2 117.00
HL TOTAL REVENUE (I + III + V + VII) 14 489.00 14 386.00 14 489.00
HM TOTAL EXPENSES (II + IV + VI + VIII + IX + X) 4 288.00 5 289.00 4 288.00
HN PROFIT OR LOSS (Total revenue - Total expenses) 10 201.00 9 096.00 10 201.00
5 - Fixed assets increase - decreaseGross value at beginning of year - Item by itemRevaluation - DisposalsAcquisition - Gross value at year-end
0G ACQUISITIONS Total General Total 23.00 45 735.00 23.00
I3 DECREASES Total Financial Fixed Assets 45 757.00
I4 DECREASES Grand Total 45 757.00
LQ ACQUISITIONS Total Financial Fixed Assets 23.00 45 735.00 23.00
8 - Receivables and payablesGross amountAmount within 1 yearAmount 1 to 5 yearsAmount more than 5 years
8B Suppliers and Related Accounts 2 000.00 2 000.00 2 000.00
8K Other liabilities (including liabilities related to repo transactions) 45 735.00 45 735.00 45 735.00
VC Group and associates 51 008.00 51 008.00 51 008.00
VG Loans with a maturity of up to one year at origin 848.00 848.00 848.00
VR Miscellaneous debtors (including receivables related to repo transactions) 5 005.00 5 005.00 5 005.00
VT TOTAL – STATEMENT OF RECEIVABLES 56 013.00 56 013.00 56 013.00
VY TOTAL – STATEMENT OF LIABILITIES 48 583.00 48 583.00 48 583.00

all companies in France

Complete and comprehensive database.